Growth Metrics

Agilon Health (AGL) Common Equity: 2020-2025

Historic Common Equity for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $306.1 million.

  • Agilon Health's Common Equity fell 4675.74% to $306.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $306.1 million, marking a year-over-year decrease of 4675.74%. This contributed to the annual value of $471.0 million for FY2024, which is 2884.19% down from last year.
  • Latest data reveals that Agilon Health reported Common Equity of $306.1 million as of Q3 2025, which was down 4675.74% from $408.9 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Common Equity registered a high of $1.2 billion during Q2 2021, and its lowest value of -$298.2 million during Q1 2021.
  • In the last 5 years, Agilon Health's Common Equity had a median value of $872.4 million in 2023 and averaged $765.2 million.
  • Per our database at Business Quant, Agilon Health's Common Equity surged by 48348.47% in 2021 and then plummeted by 4675.74% in 2025.
  • Agilon Health's Common Equity (Quarter) stood at $1.1 billion in 2021, then fell by 4.64% to $1.0 billion in 2022, then tumbled by 36.44% to $661.8 million in 2023, then decreased by 28.84% to $471.0 million in 2024, then plummeted by 35.01% to $306.1 million in 2025.
  • Its Common Equity stands at $306.1 million for Q3 2025, versus $408.9 million for Q2 2025 and $500.3 million for Q1 2025.